Repetitive Acute Intermittent Hypoxia for Spinal Cord Injury

Overseen by Monica Perez, PhD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: Shirley Ryan AbilityLab

Must not be taking: Antipsychotics, Tricyclic antidepressants

Disqualifiers: Pulmonary, Cardiovascular, Orthopedic, others

No Placebo Group

Trial Summary

What is the purpose of this trial?

Our goal is to enhance repeated exposure to acute intermittent hypoxia (rAIH)/training-induced aftereffects on upper and lower limb function recovery in humans with chronic spinal cord injury (SCI).

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are taking drugs that affect the central nervous system and lower the seizure threshold, like certain antipsychotics or tricyclic antidepressants.

What data supports the effectiveness of the treatment Repeated exposure to acute Intermittent Hypoxia (rAIH) for spinal cord injury?

Research shows that repetitive acute intermittent hypoxia (rAIH) can improve breathing and motor functions in both animal models and humans with spinal cord injuries. Studies have demonstrated that rAIH enhances respiratory function and limb movement, suggesting it may help restore some abilities in people with spinal cord injuries. ^{1 2 3 4 5}

Is repetitive acute intermittent hypoxia safe for humans?

Carefully controlled repetitive acute intermittent hypoxia (rAIH) is considered safe and noninvasive, with studies showing functional benefits without evidence of harm when low-dose protocols are used. ^{1 3 6 7 8}

How is the treatment of Repeated exposure to acute Intermittent Hypoxia (rAIH) unique for spinal cord injury?

Repeated exposure to acute Intermittent Hypoxia (rAIH) is unique because it uses brief, controlled periods of low oxygen to stimulate neuroplasticity (the brain's ability to reorganize itself) and enhance motor recovery in spinal cord injuries, which is different from traditional therapies that may not target these specific mechanisms. ^{1 3 6 7 9}

Research Team

Monica Perez, PhD

Principal Investigator

Shirley Ryan AbilityLab

Eligibility Criteria

This trial is for adults aged 18-85 with chronic spinal cord injury at or above L2, who can grip with one hand or move their wrist and ankle slightly. It's not for those with uncontrolled medical issues, recent heart problems, pregnancy, seizure history, certain medication use, previous brain injuries or conditions affecting the spine other than SCI.

Inclusion Criteria

My spinal cord injury is at or above the L2 level.

I can slightly move my toes upwards and bend my hip.

Right-handed (Only right-handed individuals will be accepted into this group because of the potential differences in the organization of the brain in right handed and left handed individuals)

Exclusion Criteria

I do not have unmanaged lung, heart, or bone problems.

You have a history of severe depression or psychosis, or ongoing problems with thinking clearly.

Your heart beats more than 120 times per minute when you are resting.

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive repeated exposure to acute Intermittent Hypoxia (rAIH) and training by research staff

6-8 weeks

Weekly visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

• Repeated exposure to acute Intermittent Hypoxia (rAIH) (Behavioural Intervention)

Trial Overview The study tests whether repeated sessions of acute intermittent hypoxia (brief periods of low oxygen) combined with upper and lower limb training can improve limb function in people with long-term spinal cord injuries.

Participant Groups

Group I: rAIH + training by research staff Active Control 3 Interventions

Participants will receive repeated exposure to acute Intermittent Hypoxia (rAIH) and training by research staff.

Group II: sham rAIH + training Placebo Group 3 Interventions

Participants will sham receive repeated exposure to acute Intermittent Hypoxia (rAIH) and training by the research staff.

Who Is Running the Clinical Trial?

Shirley Ryan AbilityLab

Lead Sponsor

Trials

212

Recruited

17,900+

U.S. Department of Education

Collaborator

Trials

87

Recruited

54,500+

Findings from Research

A single session of acute intermittent hypoxia (AIH) significantly increased maximal inspiratory pressure (MIP) in 17 adults with chronic spinal cord injury (SCI), suggesting potential for enhancing respiratory function.

While AIH improved MIP, other breathing functions like maximal expiratory pressure (MEP) and forced vital capacity (FVC) did not show significant changes, indicating that AIH may selectively affect certain respiratory muscles and highlighting the need for further research into its therapeutic effects.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Single-session effects of acute intermittent hypoxia on breathing function after human spinal cord injury. Sutor, T., Cavka, K., Vose, AK., et al.[2022]

The study found that individuals with the APOE 4 genotype showed lower diaphragm motor-evoked potential (MEP) enhancements in response to acute intermittent hypercapnic-hypoxia (AIHH), indicating that genetic factors can influence the effectiveness of this rehabilitation strategy.

Additionally, the research revealed that males had a greater enhancement in diaphragm MEP compared to females, and that age negatively affected respiratory motor plasticity, highlighting the importance of biological factors in individual responses to AIHH.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

APOE4, Age & Sex Regulate Respiratory Plasticity Elicited By Acute Intermittent Hypercapnic-Hypoxia. Nair, J., Welch, JF., Marciante, AB., et al.[2023]

A 4-week treatment combining intermittent hypoxia (IH) with body weight-supported treadmill training (BWSTT) significantly improved walking speed and endurance in individuals with incomplete spinal cord injuries (iSCI), as shown by better performance on the 10-meter walk test and 6-minute walk test.

The benefits of daily IH were maintained with a reduced frequency of treatment (3 times a week), suggesting that IH could be a safe and effective long-term therapy to enhance recovery in individuals with iSCI.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Repetitive Intermittent Hypoxia and Locomotor Training Enhances Walking Function in Incomplete Spinal Cord Injury Subjects: A Randomized, Triple-Blind, Placebo-Controlled Clinical Trial. Navarrete-Opazo, A., Alcayaga, J., Sepúlveda, O., et al.[2022]

Repetitive acute intermittent hypoxia (AIH) for 12 weeks significantly improved forelimb reach-to-grasp performance in rats with chronic cervical spinal cord injury, showing sustained benefits even 12 weeks post-treatment.

While AIH enhanced specific motor functions related to reaching tasks, it did not impact other motor tasks like ladder walking or adhesive removal, indicating that the benefits of AIH are task-specific when combined with targeted training.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Prolonged acute intermittent hypoxia improves forelimb reach-to-grasp function in a rat model of chronic cervical spinal cord injury. Arnold, BM., Toosi, BM., Caine, S., et al.[2021]

Acute intermittent hypoxia (AIH) can enhance traditional therapies for neurological dysfunction by promoting neuroplasticity and functional recovery, particularly in breathing and limb function after spinal cord injuries.

Carefully controlled repeated AIH (rAIH) is considered a safe and noninvasive treatment that can be effectively combined with physical therapy and other neurorehabilitative strategies, without causing harmful side effects.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Intermittent hypoxia and neurorehabilitation. Gonzalez-Rothi, EJ., Lee, KZ., Dale, EA., et al.[2018]

Acute intermittent hypoxia (AIH) significantly improved lower extremity muscle strength in adults with chronic incomplete spinal cord injury, with torque increasing by approximately 20% at 30 minutes and 30% at 60 minutes post-AIH.

Pretreatment with ibuprofen did not enhance the effects of AIH on muscle strength, indicating that while AIH is effective for improving leg strength, systemic inflammation management with ibuprofen may not be necessary for its benefits.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Effect of acute intermittent hypoxia on motor function in individuals with chronic spinal cord injury following ibuprofen pretreatment: A pilot study. Lynch, M., Duffell, L., Sandhu, M., et al.[2018]

References

1. United States pubmed.ncbi.nlm.nih.gov

Intermittent hypoxia and respiratory recovery in pre-clinical rodent models of incomplete cervical spinal cord injury. [2021]

2. United States pubmed.ncbi.nlm.nih.gov

Single-session effects of acute intermittent hypoxia on breathing function after human spinal cord injury. [2022]

3. United States pubmed.ncbi.nlm.nih.gov

APOE4, Age & Sex Regulate Respiratory Plasticity Elicited By Acute Intermittent Hypercapnic-Hypoxia. [2023]

4. United States pubmed.ncbi.nlm.nih.gov

Repetitive Intermittent Hypoxia and Locomotor Training Enhances Walking Function in Incomplete Spinal Cord Injury Subjects: A Randomized, Triple-Blind, Placebo-Controlled Clinical Trial. [2022]

5. United States pubmed.ncbi.nlm.nih.gov

Prolonged acute intermittent hypoxia improves forelimb reach-to-grasp function in a rat model of chronic cervical spinal cord injury. [2021]

6. United States pubmed.ncbi.nlm.nih.gov

Intermittent hypoxia and neurorehabilitation. [2018]

7. England pubmed.ncbi.nlm.nih.gov

APOE4, Age, and Sex Regulate Respiratory Plasticity Elicited by Acute Intermittent Hypercapnic-Hypoxia. [2023]

8. England pubmed.ncbi.nlm.nih.gov

Effect of acute intermittent hypoxia on motor function in individuals with chronic spinal cord injury following ibuprofen pretreatment: A pilot study. [2018]

9. United States pubmed.ncbi.nlm.nih.gov

Tetraplegia is associated with enhanced peripheral chemoreflex sensitivity and ventilatory long-term facilitation. [2022]